Literature DB >> 22045341

Clinical, virologic, and immunologic correlates of HIV-1 intraclade B dual infection among men who have sex with men.

Mary E Pacold1, Sergei L Kosakovsky Pond, Gabriel A Wagner, Wayne Delport, Daniel L Bourque, Douglas D Richman, Susan J Little, Davey M Smith.   

Abstract

OBJECTIVE: To investigate the susceptibilities to and consequences of HIV-1 dual infection.
DESIGN: We compared clinical, virologic, and immunologic factors between participants who were dually infected with HIV-1 subtype B and monoinfected controls who were matched by ongoing HIV risk factor.
METHODS: The viral load and CD4 progressions of dually and singly infected participant groups were compared with linear mixed-effects models, and individual dynamics before and after superinfection were assessed with a structural change test (Chow test). Recombination breakpoint analysis (GARD), HLA frequency analysis, and cytotoxic T-lymphocyte (CTL) epitope mapping were also performed (HIV LANL Database).
RESULTS: The viral loads of dually infected participants increased more over 3 years of follow-up than the viral loads of monoinfected controls, whereas CD4 progressions of the two groups did not differ. Viral escape from CTL responses following superinfection was observed in two participants whose superinfecting strain completely replaced the initial strain. This pattern was not seen among participants whose superinfecting virus persisted in a recombinant form with the initial virus or was only detected transiently. Several HLA types were over-represented in dually infected participants as compared to monoinfected controls.
CONCLUSIONS: These results identify potential factors for dual infection susceptibility and further define its clinical consequences.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22045341      PMCID: PMC3807679          DOI: 10.1097/QAD.0b013e32834dcd26

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  41 in total

1.  Lack of neutralizing antibody response to HIV-1 predisposes to superinfection.

Authors:  Davey M Smith; Matthew C Strain; Simon D W Frost; Satish K Pillai; Joseph K Wong; Terri Wrin; Yang Liu; Christos J Petropolous; Eric S Daar; Susan J Little; Douglas D Richman
Journal:  Virology       Date:  2006-09-07       Impact factor: 3.616

2.  Spatial discontinuities in human immunodeficiency virus type 1 quasispecies derived from epidermal Langerhans cells of a patient with AIDS and evidence for double infection.

Authors:  M Sala; G Zambruno; J P Vartanian; A Marconi; U Bertazzoni; S Wain-Hobson
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

3.  Dual human immunodeficiency virus type 1 infection and recombination in a dually exposed transfusion recipient. The Transfusion Safety Study Group.

Authors:  R S Diaz; E C Sabino; A Mayer; J W Mosley; M P Busch
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

4.  HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage.

Authors:  M Carrington; G W Nelson; M P Martin; T Kissner; D Vlahov; J J Goedert; R Kaslow; S Buchbinder; K Hoots; S J O'Brien
Journal:  Science       Date:  1999-03-12       Impact factor: 47.728

5.  HIV-1 patients may harbor viruses of different phylogenetic subtypes: implications for the evolution of the HIV/AIDS pandemic.

Authors:  D Pieniazek; L M Janini; A Ramos; A Tanuri; M Schechter; J M Peralta; A C Vicente; N K Pieniazek; G Schochetman; M A Rayfield
Journal:  Emerg Infect Dis       Date:  1995 Jul-Sep       Impact factor: 6.883

6.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Authors:  R A Koup; J T Safrit; Y Cao; C A Andrews; G McLeod; W Borkowsky; C Farthing; D D Ho
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

7.  Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells.

Authors:  Hendrik Streeck; Jonathan S Jolin; Ying Qi; Bader Yassine-Diab; Randall C Johnson; Douglas S Kwon; Marylyn M Addo; Chanson Brumme; Jean-Pierre Routy; Susan Little; Heiko K Jessen; Anthony D Kelleher; Frederick M Hecht; Rafick-Pierre Sekaly; Eric S Rosenberg; Bruce D Walker; Mary Carrington; Marcus Altfeld
Journal:  J Virol       Date:  2009-05-20       Impact factor: 5.103

8.  Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.

Authors:  P Borrow; H Lewicki; B H Hahn; G M Shaw; M B Oldstone
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

9.  Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection.

Authors:  Jianhong Cao; John McNevin; Sarah Holte; Lisa Fink; Lawrence Corey; M Juliana McElrath
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

10.  Advantage of rare HLA supertype in HIV disease progression.

Authors:  Elizabeth Trachtenberg; Bette Korber; Cristina Sollars; Thomas B Kepler; Peter T Hraber; Elizabeth Hayes; Robert Funkhouser; Michael Fugate; James Theiler; Yen S Hsu; Kevin Kunstman; Samuel Wu; John Phair; Henry Erlich; Steven Wolinsky
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

View more
  22 in total

1.  Dynamics of viral evolution and neutralizing antibody response after HIV-1 superinfection.

Authors:  Antoine Chaillon; Gabriel A Wagner; N Lance Hepler; Susan J Little; Sergei L Kosakovsky Pond; Gemma Caballero; Mary E Pacold; Pham Phung; Terri Wrin; Douglas D Richman; Joel O Wertheim; Davey M Smith
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

2.  Intrasubtype B HIV-1 Superinfection Correlates with Delayed Neutralizing Antibody Response.

Authors:  Gabriel A Wagner; Elise Landais; Gemma Caballero; Pham Phung; Sergei L Kosakovsky Pond; Pascal Poignard; Douglas D Richman; Susan J Little; Davey M Smith
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

3.  Increased HIV-1 superinfection risk in carriers of specific human leukocyte antigen alleles.

Authors:  Jouni Vesa; Antoine Chaillon; Gabriel A Wagner; Christy M Anderson; Douglas D Richman; Davey M Smith; Susan J Little
Journal:  AIDS       Date:  2017-05-15       Impact factor: 4.177

4.  Using ultradeep pyrosequencing to study HIV-1 coreceptor usage in primary and dual infection.

Authors:  Gabriel A Wagner; Mary E Pacold; Edgar Vigil; Gemma Caballero; Sheldon R Morris; Sergei L Kosakovsky Pond; Susan J Little; Douglas D Richman; Sara Gianella; Davey M Smith
Journal:  J Infect Dis       Date:  2013-04-18       Impact factor: 5.226

5.  Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment.

Authors:  George K Hightower; Joseph K Wong; Scott L Letendre; Anya A Umlauf; Ronald J Ellis; Caroline C Ignacio; Robert K Heaton; Ann C Collier; Christina M Marra; David B Clifford; Benjamin B Gelman; Justin C McArthur; Susan Morgello; David M Simpson; J A McCutchan; Igor Grant; Susan J Little; Douglas D Richman; Sergei L Kosakovsky Pond; Davey M Smith
Journal:  Virology       Date:  2012-09-20       Impact factor: 3.616

6.  HIV-associated neurocognitive disorder is associated with HIV-1 dual infection.

Authors:  Gabriel A Wagner; Antoine Chaillon; Siqi Liu; Donald R Franklin; Gemma Caballero; Sergei L Kosakovsky Pond; Florin Vaida; Robert K Heaton; Scott L Letendre; Igor Grant; Douglas D Richman; Davey M Smith
Journal:  AIDS       Date:  2016-11-13       Impact factor: 4.177

7.  HIV-1 neutralizing antibody response and viral genetic diversity characterized with next generation sequencing.

Authors:  Christoph C Carter; Gabriel A Wagner; George K Hightower; Gemma Caballero; Pham Phung; Douglas D Richman; Sergei L Kosakovsky Pond; Davey M Smith
Journal:  Virology       Date:  2014-11-11       Impact factor: 3.616

8.  Risk behaviors among HIV-positive gay and bisexual men at party-oriented vacations.

Authors:  Michael P Fisher; Rajeev Ramchand; Sarah Bana; Martin Y Iguchi
Journal:  J Stud Alcohol Drugs       Date:  2013-01       Impact factor: 2.582

9.  HIV-1 superinfection is associated with an accelerated viral load increase but has a limited impact on disease progression.

Authors:  Keshet Ronen; Barbra A Richardson; Susan M Graham; Walter Jaoko; Kishor Mandaliya; R Scott McClelland; Julie Overbaugh
Journal:  AIDS       Date:  2014-09-24       Impact factor: 4.177

Review 10.  Frequency and implications of HIV superinfection.

Authors:  Andrew D Redd; Thomas C Quinn; Aaron A R Tobian
Journal:  Lancet Infect Dis       Date:  2013-05-31       Impact factor: 25.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.